Capital Advisors Ltd’s HUMANIGEN, INC. HGEN Stock Holding History

Capital Advisors Ltd’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-252	Closed	–	–	1625
2022 Q2	$0	Buy	+252	New	+$566	﹤0.01%	1426

Other funds holding HGEN

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital Advisors Ltd's HGEN Position: Q3 2022 in Review

Capital Advisors Ltd sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 252 shares.

Capital Advisors Ltd first reported a position in HGEN in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

Capital Advisors Ltd reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
Capital Advisors Ltd sold 252 HUMANIGEN, INC. shares in Q3 2022.
Capital Advisors Ltd first reported a position in HUMANIGEN, INC. in Q2 2022 and held it in 1 quarter.
Capital Advisors Ltd's HUMANIGEN, INC. position peaked at $0 in Q2 2022.
53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Capital Advisors Ltd's 13F filing for Q3 2022, filed 9 Nov 2022.